Vet-LIRN Capacity-Building Project and Equipment Grants (U18)
Food and Drug Administration
Award ceiling
$2,500,000
Award floor
$225,000
- Opportunity #
- PAR-23-202
- Agency
- Food and Drug Administration
- ALN (CFDA)
- 93.103
- Status
- posted
- Posted
- May 18, 2023
- Closes
- Sep 4, 2028
- Funding instrument
- Cooperative Agreement
- Category
- Agriculture, Consumer Protection, Food and Nutrition
- Cost sharing required
- No
Who can apply
- •Small businesses
- •Special district governments
- •State governments
- •For profit organizations other than small businesses
- •Native American tribal governments (Federally recognized)
- •Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- •County governments
- •Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- •Public and State controlled institutions of higher education
- •Independent school districts
- •Public housing authorities/Indian housing authorities
- •Private institutions of higher education
- •City or township governments
- •Native American tribal organizations (other than Federally recognized tribal governments)
Synopsis
The goal of this NOFO is to fund veterinary diagnostic laboratories in the Vet-LIRN network for grants associated with projects and equipment. Specific objectives include:
1. Supporting the development, adaptation, or verification/validation of new methods associated with animal food issues or antimicrobial resistance.
2. Short-term surveillance or monitoring efforts aligned with the CVM mission.
3. Supporting equipment for testing or developing tests associated with animal food-related issues or antimicrobial resistance, including those for emerging technologies.
4. Developing projects related to antimicrobial stewardship, in alignment with CVM's key initiatives in this area.
5. Contributing as part of Vet-LIRN's AMR monitoring program, including sequencing isolates.
6. Supporting work associated with One Health, including emerging diseases such as COVID-19, when funding is available.
Contact
Rene A Vasquez Grantor · kimberly.pendleton@fda.hhs.gov